The CRO of ZM, Ryan Azus has gone ahead and sold around 6,250 shares of the company in a 21st April research report. The average price at which the stocks were sold was $319.61, with the total value coming in at $1,997,562. Currently, the CRO has ownership of around 41,917 shares of the company which has a total valuation of around $13,397,092.37. The documentation is available on the official SEC website.
The Quarterly Estimates of ZM
The stocks of ZM traded on Friday at $336.88. The year low of the company during this period was $132.67, with the year high set at $588.84. The market cap of the firm is $98.95 billion, with a 431.90 PE ratio, and a 12.42 PEG ratio. The moving average price of the firm over 50 days is $329.01, with the moving average price of the company over 200 days set at $397.47.
ZM had previously updated its quarterly report on the 28th of February. The EPS reported by the company over the period was $1.22 which was slightly less than the consensus estimate of around $0.79. The net margin for the company was 17.10%, with a 27.93% return on equity. The revenue generated during this period was $882.49 million, which is more than the consensus estimate of $810.97 million.
There have been quite a few research equities that have commented on the stocks of ZM. Morgan Stanley has already increased the price target to $420 with a rating of equal weight in an 8th March research report. Deutsche Bank has also increased the rating to hold, with a price target of $360 set on the company. Rosenblatt Securities has increased the price target of the company to $400 with a rating of neutral in an 8th March research report. The Bank of America has also put up a rating of buy in a Tuesday research report.
Three of the investment analysts have given the stocks a rating of sell, while eleven have already issued it with a rating of buy. Currently, ZM has a hold rating with a $423.62 price target.
